Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929755 · ClinicalTrials.gov registry record · Phase 4
Depo-Medrol on Psoas After LLIF
A Phase 4 study of Pain, Postoperative and Muscle Weakness, sponsored by Hardeep Singh.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05929755: Recruiting Phase 4 study of Pain, Postoperative and Muscle Weakness, sponsored by Hardeep Singh.
NCT05929755 is a Phase 4 study of Pain, Postoperative and Muscle Weakness that is actively recruiting participants, run by Hardeep Singh. The registered enrollment target is 80 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05929755, a Phase 4 study of Pain, Postoperative and Muscle Weakness, is actively recruiting participants, sponsored by Hardeep Singh.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.
Primary Outcome
Visual Analog Scale (VAS) - Anterior Thigh Pain How would you evaluate the pain you are feeling today at the front of your thigh on a scale from "no pain" to "worst pain imaginable"?
Conditions Studied
Interventions
- DRUG Depo-Medrol
- DRUG Gel-Flow NT
Study Locations (1)
Connecticut
- UConn Health - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2027-05 |
| Phase | Phase 4 |
What NCT05929755 shows while recruiting
NCT05929755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (71% lower).
The record links to 4 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Depo-Medrol is the first listed.
NCT05929755 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05929755 about?
NCT05929755 is a clinical study titled "Depo-Medrol on Psoas After LLIF". The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.
What is the current status of trial NCT05929755?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2023-05-12. Estimated completion is 2027-05.
What conditions does trial NCT05929755 study?
This clinical trial studies the following conditions: Pain, Postoperative, Muscle Weakness, Paresthesia, Pain, Muscle.
What interventions are being tested in trial NCT05929755?
The interventions under investigation include: Depo-Medrol (DRUG), Gel-Flow NT (DRUG).
Who is sponsoring clinical trial NCT05929755?
This trial is sponsored by Hardeep Singh, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929755 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05929755's enrollment target sits among peer trials
80 56th of 113 higher than 53 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI